Cancer researchers at the University of Cincinnati (UC) College of Medicine have found an obesity-associated protein's role in leukemia development and drug response which could lead to more effective therapies for the illness.
Dec 22, 2016
0
1
A professor at The University of New Mexico has developed a new, groundbreaking drug that that could revolutionize the diagnosis of infectious diseases.
Dec 2, 2016
0
2
A group of researchers from Columbia University, Rutgers University, and institutions in Europe and Japan have identified genomic alterations in pediatric relapsed acute lymphoblastic leukemia (ALL) that cause both therapy ...
Sep 22, 2016
0
0
(HealthDay)—New anticancer drugs, which increase costs considerably, are associated with large gains in life expectancy, according to research published in the September issue of Health Affairs.
Sep 13, 2016
0
1
A study of an experimental treatment for leukemia that was halted last week following two patient deaths has been allowed to resume after a modification.
Jul 12, 2016
0
5
For the first time, researchers have discovered that some leukemia cells harvest energy resources from normal cells during chemotherapy, helping the cancer cells not only to survive, but actually thrive, after treatment.
Jun 2, 2016
0
7
Acute lymphoblastic leukemia (ALL) is the most common type of childhood cancer in Switzerland. Despite intensive chemotherapy, one fifth of the patients suffer a relapse, which usually goes hand in hand with a poor prognosis. ...
May 18, 2016
0
22
Cancer cells have an abnormal cell division and survival machinery - they grow faster than they die. For their permanent development, they produce an excess of growth factors and nutrients and block the body's own safety ...
May 17, 2016
0
33
The multiple sclerosis (MS) drug mitoxantrone may be associated with an increased risk of colorectal cancer, according to a study published in the May 11, 2016, online issue of Neurology, the medical journal of the American ...
May 11, 2016
0
6
(HealthDay)—Venclexta (venetoclax) has been approved by the U.S. Food and Drug Administration to treat chronic lymphocytic leukemia (CLL) characterized by a specific chromosomal abnormality called the 17p deletion.
Apr 11, 2016
0
0
